학술논문
A novel high-dose mesalazine tablet is as effective as conventional low-dose mesalazine tablets in inducing remission in patients with mildly to moderately active ulcerative colitis (UC): A double-blind, double-dummy, multicentre, randomised trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
18764479